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INTRODUCTION 
              Leptospirosis is a worldwide zoonotic infection with a much 
greater incidence in tropical regions and has now been identified as one of the 
emerging infectious diseases. The epidemiology of leptospirosis has been 
modified by changes in animal husbandry, climate, and human behavior. 
Resurgent interest in leptospirosis has resulted from large outbreaks that have 
received significant publicity. Awareness has increased internationally over 
the past decade that leptospirosis is a major globally important public health 
threat, both in developing countries and industrialized countries. The 
economic burden imposed by this disease is unknown, yet it is widely 
recognized that the incidence of leptospirosis is remarkably underestimated 
and the disease under diagnosed in endemic regions. Leptospirosis is 
estimated to affect tens of millions of humans annually with case fatality rates 
ranging from 5 to 25%. Case finding and reporting have been limited, 
nonsustained and biased. 
                        This study of incidence and clinical profile of leptospirosis 
Among patients presenting with fever and jaundice was conducted in 
Thanjavur Medical College Hospital, Thanjavur, sofar a non-endemic region 
for Leptospirosis. Though cases of Leptospirosis occur sporadically in this 
hospital a study about the clinical profile is essential in epidemiological 
aspect. 
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AIM OF THIS STUDY 
 
 
1. To study the incidence of Leptospirosis among unexplained 
fever and jaundice cases admitted in TMCH. 
2. To analyze the relevant epidemiological data like seasonal 
and demographic clustering of cases. 
3. To analyze the occupation of seropositive cases.                            
4. To analyze the clinical features among the positive cases 
confirmed by serology.  
5. To analyze the Investigations done on seropositive cases.  
6. To study the incidence of complications. 
7. To analyze about the outcome among positive cases. 
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REVIEW OF LITERATURE 
HISTORY: 
                      Leptospirosis was certainly recognized as an occupational 
hazard of rice harvesting in ancient China ,and the Japanese name akiyami, or 
autumn fever, persists in modern medicine1. With hindsight, clear descriptions 
of leptospiral jaundice can be recognized as having appeared earlier in the 
19th century, some years before the description by Weil in 1886. The etiology 
of leptospirosis was demonstrated independently in 1915 in Japan and 
Germany. In Japan, Inada and Ido detected both spirochetes and specific 
antibodies in the blood of Japanese miners with infectious jaundice, and two 
groups of German physicians studied German soldiers afflicted by "French 
disease" in the trenches of northeast France. Uhlenhuth and Fromme and 
Hubener and Reiter, detected spirochetes in the blood of guinea pigs 
inoculated with the blood of infected soldiers1.  
                             The importance of occupation as a risk factor was recognized 
early. The role of the rat as a source of human infection was discovered in 
1917. while the potential for leptospiral disease in dogs was recognized, but 
clear distinction between canine infection with L. interrogans serovars 
icterohaemorrhagiae and canicola took several years.  Leptospirosis in 
livestock was recognized some years later8. 
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CAUSATIVE  ORGANISM: 
Biology of Leptospires:  
                  Leptospires are tightly coiled spirochetes, usually 0.1 µm by 6 to 
0.1 by 20 µm, (leptos- meaning fine or thin). The cells have pointed ends, 
either or both of which are usually bent into a distinctive hook .Two axial 
filaments (periplasmic flagella) with polar insertions are located in the 
periplasmic space. Leptospires exhibit two distinct forms of movement, 
translational and nontranslational. Leptospiral lipopolysaccharide has a 
composition similar to that of other gram-negative bacteria ,but has lower 
endotoxic activity. Leptospires are obligate aerobes with an optimum growth 
temperature of 28 to 30°C. They produce both catalase and oxidase . They 
grow in simple media enriched with vitamins (vitamins B2 and B12 are growth 
factors), long-chain fatty acids, and ammonium salts . Long-chain fatty acids 
are utilized as the sole carbon source and are metabolized by  -oxidation1,2,50. 
Culture Methods: 
                  Growth of leptospires in media containing either serum or albumin 
plus polysorbate and in protein-free synthetic media has been described. 
Several liquid media containing rabbit serum were described by Fletcher, 
Korthoff, Noguchi, and Stuart. The most widely used medium in current 
practice is based on the oleic acid-albumin medium EMJH. It contains Tween 
80 and bovine serum albumin1,50. 
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Scanning electron micrograph of 
L. interrogans  serovar icterohaemorrhagiae strain 
bound to a 0.2-µm membrane filter1,2 
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CLASSIFICATION 
Serological classification:   Prior to 1989, the genus Leptospira was divided 
into two species, L. interrogans, comprising all pathogenic strains, and 
L. biflexa, containing the saprophytic strains isolated from the environment. 
L. biflexa was differentiated from L. interrogans by the growth of the former 
at 13°C and growth in the presence of 8-azaguanine (225 µg/ml) and by the 
failure of L. biflexa to form spherical cells in 1 M NaCl.  
                    Both L. interrogans and L. biflexa are divided into numerous 
serovars defined by agglutination after cross-absorption with homologous 
antigen . If more than 10% of the homologous titer remains in at least one of 
the two antisera on repeated testing, two strains are said to belong to different 
serovars . Over 60 serovars of L. biflexa have been recorded . Within the 
species L. interrogans over 200 serovars are recognized; additional serovars 
have been isolated but have yet to be validly published. Serovars that are 
antigenically related have traditionally been grouped into serogroups . While 
serogroups have no taxonomic standing, they have proved useful for 
epidemiological understanding. 
Genotypic classification:     The phenotypic classification of leptospires has 
been replaced by a genotypic one, in which a number of genomospecies 
include all serovars of both L. interrogans and L. biflexa. Genetic 
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heterogeneity was demonstrated some time ago, and DNA hybridization 
studies led to the definition of 10 genomospecies of Leptospira . An additional 
genomospecies, L. kirschneri, was added later. After an extensive study of 
several hundred strains, workers at the Centers for Disease Control (CDC) 
more recently defined 16 genomospecies of Leptospira that included those 
described previously  and adding five new genomospecies , one of which was 
named L. alexanderi. An additional species, L. fainei, has since been 
described, which contains a new serovar, hurstbridge . The genotypic 
classification of leptospires is supported by multilocus enzyme electrophoresis 
data ,but recent studies suggest that further taxonomic revisions are likely .The 
genomospecies of Leptospira do not correspond to the previous two species 
(L. interrogans and L. biflexa), and indeed, pathogenic and nonpathogenic 
serovars occur within the same species. Thus, neither serogroup nor serovar 
reliably predicts the species of Leptospira . Moreover, recent studies have 
included multiple strains of some serovars and demonstrated genetic 
heterogeneity within serovars. In addition, the phenotypic characteristics 
formerly used to differentiate L. interrogans sensu lato from L. biflexa sensu 
lato do not differentiate the genomospecies.  
        The reclassification of leptospires on genotypic grounds is taxonom- 
ically correct and provides a strong foundation for future classifications.  
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Species of Leptospira and some Pathogenic Serovars2 
Species Selected Pathogenic Serovars 
L. interrogans Icterohaemorrhagiae, Copenhageni, Canicola, 
Pomana, Australis, Autumnalis, Pyrogenes, 
Bratislava, Lai. 
L. noguchii Panama, Pomona. 
L. borgpetersenii Ballum, Hardjo, Javanica. 
L. santarosai Bataviae. 
L. kirschneri Bim, Bulgarica, Grippotyphosa, Cynopteri. 
L. weilii Celledoni, Sarmin. 
L. alexanderi Manhao 3. 
Leptospira genomspecies 1 Sichuan. 
L. fainei Hurstbridge. 
L. Meyeri Sofia 
L. Inadai Indeterminate 
L. wolbachii Non-pathogens 
L. biflexa Non-pathogens 
Leptospira genomspecies 3 Non-pathogens 
Leptospira genomspecies 4 Non-pathogens 
Leptospira genomspecies 5 Non-pathogens 
L. parva Non-pathogens 
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EPIDEMIOLOGY: 
                       Leptospirosis is presumed to be the most widespread zoonosis 
in the world1 . The source of infection in humans is usually either direct or 
indirect contact with the urine of an infected animal. The incidence is 
significantly higher in warm-climate countries than in temperate regions; this 
is due mainly to longer survival of leptospires in the environment in warm, 
humid conditions. However, most tropical countries are also developing 
countries, and there are greater opportunities for exposure of the human 
population to infected animals, whether livestock, domestic pets, or wild or 
feral animals. The disease is seasonal, with peak incidence occurring in 
summer or fall in temperate regions, where temperature is the limiting factor 
in survival of leptospires, and during rainy seasons in warm-climate regions, 
where rapid dessication would otherwise prevent survival. 
                       The usual portal of entry is through abrasions or cuts in the skin 
or via the conjunctiva; infection may take place via intact skin after prolonged 
immersion in water, but this usually occurs when abrasions are likely to occur 
and is thus difficult to substantiate. Water-borne transmission has been 
documented; point contamination of water supplies has resulted in several 
outbreaks of leptospirosis . Inhalation of water or aerosols also may result in 
infection via the mucous membranes of the respiratory tract. Rarely, infection 
may follow animal bites. Direct transmission between humans has been 
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demonstrated rarely. However, excretion of leptospires in human urine months 
after recovery has been recorded. It is thought that the low pH of human urine 
limits survival of leptospires after excretion. Transmission by sexual 
intercourse during convalescence has been reported1. 
                       Animals, including humans, can be divided into maintenance 
hosts and accidental (incidental) hosts. The disease is maintained in nature by 
chronic infection of the renal tubules of maintenance hosts . A maintenance 
host is defined as a species in which infection is endemic and is usually 
transferred from animal to animal by direct contact. Infection is usually 
acquired at an early age, and the prevalence of chronic excretion in the urine 
increases with the age of the animal. Other animals (such as humans) may 
become infected by indirect contact with the maintenance host. Animals may 
be maintenance hosts of some serovars but incidental hosts of others, infection 
with which may cause severe or fatal disease. The most important 
maintenance hosts are small mammals, which may transfer infection to 
domestic farm animals, dogs, and humans. The extent to which infection is 
transmitted depends on many factors, including climate, population density, 
and the degree of contact between maintenance and accidental hosts. Different 
rodent species may be reservoirs of distinct serovars, but rats are generally 
maintenance hosts for serovars of the serogroups lcterohaemorrhagiae and 
Ballum, and mice are the maintenance hosts for serogroup Ballum. Domestic 
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animals are also maintenance hosts; dairy cattle may harbor serovars hardjo, 
pomona, and grippotyphosa; pigs may harbor pomona, tarassovi, or bratislava; 
sheep may harbor hardjo and pomona; and dogs may harbor canicola 
           Human infections may be acquired through occupational, 
recreational, or vocational exposures. Occupation is a significant risk factor 
for humans. Direct contact with infected animals accounts for most infections 
in farmers, veterinarians, abattoir workers, meat inspectors, rodent control 
workers, and other occupations which require contact with animals. Indirect 
contact is important for sewer workers, miners, soldiers, septic tank cleaners, 
fish farmers, gamekeepers, canal workers, rice field workers, taro farmers, 
banana farmers, and sugar cane cutters.1, 44, 55  
                         Survival of pathogenic leptospires in the environment is 
dependent on several factors, including pH, temperature, and the presence of 
inhibitory compounds. Most studies have used single serovars and quite 
different methodologies, but some broad conclusions may be drawn. Under 
laboratory conditions, leptospires in water at room temperature remain viable 
for several months at pH 7.2 to 8.0, but in river water survival is shorter and is 
prolonged at lower temperatures. The presence of domestic sewage decreases 
the survival time to a matter of hours, but in an oxidation ditch filled with 
cattle slurry, viable leptospires were detected for several weeks 
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Important Leptospiral Infections50 
Serotype Disease Clinical Picture Animal Reservoir Distribution 
Icterohemorrhagiae Weils Disease 
Fever, jaundice, 
hemorrhages 
Rat Worldwide 
Canicola Canicola fever 
Influenza like, 
aseptic meningitis 
Dog Worldwide 
Grippotyphosa 
Swamp or marsh 
fever 
Fever, prostration, 
aseptic meningitis 
Field mice 
Europe. Africa, 
SE Asia, USA 
Pomona 
Swineherd’s 
disease 
Fever Pig 
America, 
Europe, Middle 
East, Indonesia, 
Australia 
Hebdomadis Seven day fever 
Fever, 
Lymphadenopathy 
Field mice 
Japan, Europe, 
USA 
Fortbragg 
Pretibial fever 
Fortbragg fever 
Fever, rash over 
tibia 
Not known 
Japan, SE Asia, 
USA 
Pyrogenes 
Febrile 
Spirochetosis 
Fever Pig 
SE Asia, 
Europe, USA 
Bataviae 
Indonesian Weil’s 
disease 
Fever Rat 
SE Asia, Africa, 
Europe 
Hardjo Dairy farm fever Fever Cattle 
UK, USA, New 
Zealand 
 
 PATHOLOGY AND PATHOGENESIS.  
                               Leptospira penetrate intact mucous membranes and 
abraded skin and disseminate widely via the bloodstream. Leptospirosis is an 
infectious vasculitis, with damage to capillary endothelial cells responsible for 
the major clinical manifestations of disease, including renal tubular and 
hepatic dysfunction, myocarditis, and pulmonary hemorrhage. Intra- to extra 
vascular fluid shifts secondary to endothelial damage lead to hypovolemia, 
which complicates renal dysfunction and can lead to shock. Fatal cases are 
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associated with widespread hemorrhage of mucosal, skin, and serosal 
surfaces. 
        In LIVER, the damage is at the subcellular level. An endotoxin-
like substance in the wall of Spirochetes has been suggested. Plasma TNF-α 
levels have been related to severity of organ involvement. Liver necrosis is 
minimal and focal. Zone 3 necrosis is absent. Active hepatocellular 
regeneration is out of proportion to the cell damage. Swollen Kupfer cells 
have Leptospiral debris. Leucocyte infiltration and bile thrombi are prominent 
in deeply jaundiced. Cirrhosis is not a sequela.53 
                 Examination of the Kidneys from autopsies23 has revealed ischemic 
damage, including epithelial cell necrosis in the distal convoluted tubules and 
the ascending loop of Henle, and interstitial nephritis but only rarely 
glomerular damage. Muscle biopsies have demonstrated focal necrotic 
changes with a mild mononuclear infiltrate. Only rarely is the spirochete 
visualized in the infected tissue. Hemorrhagic myocarditis2,42 has been 
observed frequently in autopsies. The secondary "immune" phase of 
leptospirosis is associated with the clearance of the organism from blood and 
CSF and the appearance of agglutinating anti-Leptospira antibodies. 
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Possible Determinants of Leptospiral Severity: 54 
 Virulence properties of infecting Leptospira. 
 Infectious inoculum at the time of exposure. 
 Preexisting immunity due to previous exposure. 
 Hormonal influences (men more commonly develop severe disease). 
 Human host Genetics: Acquired or innate immunity. 
 Nutritional factors: malnutrition, alcohol consumption. 
 
CLINICAL FEATURES: 
                       Symptoms develop 7 to 12 days after exposure. The clinical 
presentation of leptospirosis is biphasic, with the acute or septicemic phase 
lasting about a week,  followed by the immune phase, characterized by 
antibody production and excretion of leptospires in the urine.  Most of the 
complications of leptospirosis are associated with localization of leptospires 
within the tissues during the immune phase and thus occur during the second 
week of the illness1. 
Anicteric Leptospirosis: 
                      The great majority of infections caused by leptospires are either 
sub clinical or of very mild severity, and patients will probably not seek 
medical attention. A smaller proportion of infections, but the overwhelming 
majority of the recognized cases, present with a febrile illness of sudden onset. 
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Other symptoms include chills, headache, myalgia, abdominal pain, 
conjunctival suffusion, and less often a skin rash. If present, the rash is often 
transient, lasting less than 24 h. The fever may be biphasic and may recur after 
a remission of 3 to 4 days. The headache is often severe, resembling that 
occurring in dengue, with retro-orbital pain and photophobia. Myalgia 
affecting the lower back, thighs, and calves is often intense. This anicteric 
syndrome usually lasts for about a week, and its resolution coincides with the 
appearance of antibodies.  
Icteric Leptospirosis  
                   Icteric leptospirosis is a much more severe disease in which the 
clinical course is often very rapidly progressive. Between 5 and 10% of all 
patients with leptospirosis have the icteric form of the disease. Severe cases 
often present late in the course of the disease, and this contributes to the high 
mortality rate, which ranges between 5 and 15%. The jaundice occurring in 
leptospirosis is not associated with hepatocellular necrosis, and liver function 
returns to normal after recovery. Serum bilirubin levels may be high, and 
many weeks may be required for normalization. There are moderate rises in 
transaminase levels, and minor elevation of the alkaline phosphatase level 
usually occurs. 
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     The important Differential Diagnosis includes severe falciparum 
malaria, enteric fever, viral hepatitis and dengue hemorrhagic fever. In India, 
the seasonal pattern of leptospirosis coincides with that of malaria. Rickettsia 
tsutsugamushi infection and Hanta virus infection produce clinical a illness 
identical to severe leptospirosis. Serology differentiates the illnesses.7 
 
Difference between Weil’s Disease and Viral Hepatitis: 53 
 
 Weils Disease Viral Hepatitis 
Onset Sudden Gradual 
Headache Constant Occasional 
Muscle Pain Severe Mild 
Conjunctival Suffusion Present Absent 
Prostration Great Mild 
Disorientation Common Rare 
Bleeding diathesis Common Rare 
Nausea/Vomiting Present Present 
Abdominal Discomfort Common Common 
Bronchitis Common Rare 
Albuminuria Present Absent 
Leucocyte count Polymorph leucocytosis 
Leucopenia with 
lymphocytosis 
Creatine Phospho kinase Elevated Usually normal 
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COMPLICATIONS 
                   The complications of severe leptospirosis emphasize the 
multisystemic nature of the disease. Renal  involvement is common in 
leptospirosis.14,15,16 Bacterial invasion, inflammatory process, haemodynamic 
alterations and direct toxicity of bacterial products are thought to be 
responsible for the development of nephropathy. Pathologically, all renal 
structures are involved. Interstitial nephritis is the basic lesion, and is 
observed even in patients without clinical renal manifestations. Tubular 
necrosis is the important pathological counterpart of acute renal failure. The 
clinical spectrum of renal manifestations includes mild urinary sediment 
change, hypokalemia, tubular dysfunction, decreased response to fluid load 
and acute renal failure (ARF) 22. Leptospirosis is a common cause of acute 
renal failure (ARF), which occurs in 16 to 40% of cases. A distinction may be 
made between patients with prerenal azotemia (non-ARF) and those with 
ARF. Patients with prerenal azotaemia may respond to rehydration, and 
decisions regarding dialysis can be delayed for up to 72 h.  ARF reflects the 
severity of leptospirosis, is catabolic and is commonly associated with 
cholestatic jaundice. Severe renal failure may be complicated by multiple 
organ involvement. 22 
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          Renal failure with hyperbilirubinemia represents a severe form of 
renal dysfunction with oligo-anuria and prolonged clinical course. Mild renal 
failure is usually anicteric and non-oliguric and without complication. Besides 
antibiotic treatment, early and frequent dialysis is life saving. ARF with major 
organ failure has unfavorable outcome.   
                  Pulmonary hemorrhage may be severe enough to cause death. 
Patients may present with a spectrum of symptoms, ranging from cough, 
dyspnea, and hemoptysis to adult respiratory distress syndrome. Radiography 
generally reveals diffuse small opacities which may be widely disseminated or 
which may coalesce into larger areas of consolidation, with increasing severity 
of symptoms. Pleural effusions may occur.2,24,36. 
                  Clinical evidence of myocardial involvement, including abnormal 
T waves may be seen.2,24,42. 
Ocular Involvement:    
       Conjunctival suffusion is seen in the majority of patients in some 
series. Conjunctival suffusion in the presence of scleral icterus is said to be 
pathognomonic of Weil's disease. Anterior uveitis, either unilateral or bilateral, 
occurs after recovery from the acute illness in a minority of cases. Uveitis may 
present weeks, months, or occasionally years after the acute stage. Chronic 
visual disturbance, persisting 20 years or more after the acute illness, has been 
reported.38 
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Hypopyon and Cataract in Leptospiral uveitis38 
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Other Complications     
                      Acute infection in pregnancy has been reported to cause 
abortion and fetal death. In one of the cases reported by Chung et al., 
leptospires were isolated from amniotic fluid, placenta, and cord blood; the 
infant was mildly ill and was discharged at 2 weeks of age. In another case, a 
neonate developed jaundice and died 2 days after birth.2,24  
             Rare complications include cerebrovascular accidents, 
rhabdomyolysis, thrombotic thrombocytopenic purpura, acute acalculous 
cholecystitis, erythema nodosum, aortic stenosis, Kawasaki syndrome, 
reactive arthritis, epididymitis, nerve palsy, male hypogonadism, and Guillain-
Barré syndrome. Cerebral arteritis, resembling Moyamoya disease, has been 
reported in a series of patients from China.24 
     
 
Biphasic nature of leptospirosis and relevant investigations at different stages of disease. Specimens 1 and 2 for serology are 
acute-phase specimens, 3 is a convalescent-phase sample which may facilitate detection of a delayed immune response, and 4 and 
5 are follow-up samples which can provide epidemiological information, such as the presumptive infecting serogroup. 1,2,3 
DIAGNOSIS 
Microscopic Demonstration  
                    Leptospires may be visualized in clinical material by dark-field 
microscopy or by immunofluorescence or light microscopy after appropriate 
staining50. Approximately 10 leptospires/ml are necessary for one cell per 
field to be visible by dark-ground microscopy (DGM). A quantitative buffy 
coat method has been shown to have a sensitivity of approximately 10 
leptospires/ml. Microscopy of blood is of value only during the first few days 
of the acute illness, while leptospiremia occurs1. Dark-field microscopic 
examination of body fluids such as blood, urine, CSF, and dialysate fluid has 
been used but is both insensitive and lacks specificity. The drawbacks of 
DGM on clinical specimens as a diagnostic tool has been that both false 
positive and false negative diagnosis can be easily made even in experienced 
hands. 
                   Staining methods have been applied to increase the sensitivity of 
direct microscopic examination. These include immunofluorescence staining 
of bovine urine, water, and soil and immunoperoxidase staining of blood and 
urine. A variety of histopathological stains have been applied to the detection 
of leptospires in tissues. Leptospires were first visualized by silver staining, 
and the Warthin-Starry stain is widely used for histologic examination. 
Recently, immunohistochemical methods have been applied.  
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Leptospires viewed by dark-field microscopy 
(original magnification × 100). 
 
 
 
Section from liver showing mononuclear inflammation in portal tracts 
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Kidney sections stained by silver staining showing presence of multiple 
leptospires in tubules.2 
 
 
 
Kidney sections stained by immunohistochemical staining showing presence 
of multiple leptospires in tubules. 2 
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Culture 
Isolation of Leptospires: 
                        Leptospiremia occurs during the first stage of the disease, 
beginning before the onset of symptoms, and ends by the first week of the 
illness. Therefore blood cultures should be taken as soon as possible after the 
patient's presentation. One or two drops of blood are inoculated into 10 ml of 
semisolid medium containing 5-fluorouracil at the patient's bedside. For the 
greatest recovery rate, multiple cultures should be performed, but this is rarely 
possible. Inoculation of media with dilutions of blood samples may increase 
recovery. Rapid detection of leptospires by radiometric methods has been 
described. Leptospires survive in conventional blood culture media for a 
number of days. Rarely, leptospires have been isolated from blood weeks after 
the onset of symptoms. Isolation of leptospires from clinical samples gives a 
definitive diagnosis and also aids in identifying the prevalent serovar1,20. 
                       Apart from blood, CSF and dialysate fluid can also be cultured 
during the first week of illness. Urine can be cultured from the beginning of 
the second week of symptomatic illness. The duration of urinary excretion 
varies but may last for several weeks. Survival of leptospires in voided human 
urine is limited, so urine should be immediately centrifuged, followed by 
resuspending the sediment in phosphate-buffered saline (to neutralize the pH) 
and inoculating into semisolid medium containing 5-fluorouracil. 
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                    Cultures are incubated at 28 to 30°C and examined weekly by 
dark-field microscopy for up to 13 weeks before being discarded. 
Contaminated cultures may be passed through a 0.2-µm or 0.45-µm filter 
before subculture into fresh medium. 
                    Though the use of culture confirms diagnosis, it is rarely used, as 
it is very tedious, complicated, expensive, technically demanding, time 
consuming, requiring prolonged incubation (minimum 1 month before 
declaring a sample negative) and may not be successful (low sensitivity). The 
organism also has a relatively long doubling time (6 to 8 h or more). 
Additionally they are highly infectious organisms requiring 'Biosafety level II' 
facilities.  
 
Susceptibility testing:  
Leptospires are susceptible to beta-lactams, macrolides, tetracyclines, 
fluoroquinolones and streptomycin. Problems in the determination of 
susceptibility include the long incubation time required, the use of media 
containing serum and the difficulty in quantifying growth accurately. These 
constraints have limited the development of rapid, standardized methods for 
susceptibility testing.  
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Antigen detection  
                    Detection of leptospiral antigens in clinical material offer greater 
specificity than DGM while having the potential for greater sensitivity. 
Radioimmunoassay (RIA) can detect 104sub to 105sub leptospires/ml and an 
enzyme-linked immunosorbent assay (ELISA) method can detect 105sub 
leptospires/ml. A chemiluminescent immunoassay (CLIA) has been applied to 
human blood and urine but has been less sensitive than earlier ELISA. 
Recently, immunomagnetic antigen capture has been combined with 
fluoroimmunoassay to detect as few as 102sub leptospires/ml in urine of cattle 
infected with serovar hardjo .  
 
 
 
 
 
 
 
 
Genus-specific serological tests for diagnosis of Leptospirosis1 
 
• Complement fixation test 
• Sensitized erythrocyte lysis 
• Macroscopic slide agglutination 
• Immunfluorescence 
• Patoc slide agglutination test 
• Indirect hemagglutination 
• Counterimmunoelectrophoresis 
• ELISA 
• Microcapsule agglutination 
• Dot-ELISA 
• IgM dipstick 
• Latex agglutination 
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Antibody detection  
                    Most cases of leptospirosis are diagnosed by serology. Antibodies 
can become detectable by the 6th to 10th day of disease and generally reach 
peak levels within 3 to 4 weeks. Antibody levels then gradually recede but 
may remain detectable for years. Serological methods can be divided into two 
groups: those, which are genus specific and those which are serogroup 
specific. The definitive serological investigation in leptospirosis remains the 
microscopic agglutination test (MAT). 
Microscopic agglutination test (MAT):  
                 The reference method for serological diagnosis of leptospirosis is 
the MAT, in which patient sera are reacted with live antigen suspensions of 
leptospiral serovars1. After incubation, the serum-antigen mixtures are 
examined microscopically for agglutination and the titers are determined. 
Formerly, the method was known as the agglutination-lysis test because of the 
formation of lysis balls or lysis globules of cellular debris in the presence of 
high-titered antiserum. However, these are tightly agglutinated clumps of 
leptospires containing live cells and not debris. Several modifications of 
earlier methods led to a MAT method, which can be performed and read in 
microtiter trays. The MAT is read by dark-field microscopy. The end point is 
the highest dilution of serum at which 50% agglutination occurs. Because of 
the difficulty in detecting when 50% of the leptospires are agglutinated, the 
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end point is determined by the presence of approximately 50% free, 
unagglutinated leptospires compared to the control suspension Considerable 
effort is required to reduce the subjective effect of observer variation, even 
within laboratories20. Different laboratories use different cut-off titres ranging 
from 1 in 100 to 1 in 800 for diagnosis and may result in overdiagnosis and 
overestimation of disease burden. The importance of determination of base 
line titres in the community hence cannot be overemphasised.  
                       Interpretation of this test is complicated by the high degree of 
cross-reaction that occurs between different serogroups, especially in acute-
phase samples. This is to some extent predictable, and patients often have 
similar titers to all serovars of an individual serogroup. Of note, "paradoxical" 
reactions in which the highest titers are detected to a serogroup unrelated to 
the infecting one, are also common. Thus MAT is a complex test to control, 
perform, and interpret. Live cultures of all serovars required for use as 
antigens need to be maintained. Moreover, the repeated weekly subculture of 
large numbers of strains presents hazards for laboratory workers20. 
                       Paired sera are required to confirm a diagnosis with certainty.  
A fourfold or greater rise in titer between paired sera confirms the diagnosis 
regardless of the interval between samples2,3,5,6. The interval between the first 
and second samples greatly depends on the delay between onset of symptoms 
and presentation of the patient. If symptoms of overt leptospirosis are present, 
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an interval of 3 to 5 days may be adequate to detect rising titers. However, if 
the patient presents earlier in the course of the disease or if the date of onset is 
not known precisely, then an interval of 10 to 14 days between samples is 
more appropriate1,20.  
                     In the Current CDC Case Definition, a titer of   200 is used to 
define a probable case with a clinically compatible illness.1,4 In areas where 
leptospirosis is endemic, a single titer of 800 in symptomatic patients is  
indicative of leptospirosis. The  National Institute of Communicable Diseases 
(NICD), New Delhi Case Definition also advocates a MAT titre of >200.5 
Other Serological Tests  
                  Because of the complexity of the MAT, rapid screening tests for 
leptospiral antibodies in acute infection have been developed. Complement 
fixation (CF) was widely used but methods were not standardized. CF tests 
have generally been replaced by ELISA methods.  
                  IgM antibodies become detectable during the first week of illness 
allowing the diagnosis to be confirmed and treatment initiated while it is 
likely to be most effective. Antibody levels are generally low or absent during 
very early infection. IgM detection has repeatedly been shown to be more 
sensitive than MAT when the first specimen is taken early in the acute phase 
of the illness. However most of the commercially available ELISA kits use 
non-pathogenic L.biflexa patoc 1 strain as an antigen. The drawback of this 
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test is that the infective serovar cannot be assessed. Though the test is more 
sensitive than MAT it is less specific.  
                  An IgM-specific dot-ELISA has been developed in which 
polyvalent leptospiral antigen was dotted onto nitrocellulose filter disks in 
microtiter tray wells, allowing the use of smaller volumes of reagents. Further 
modifications of this approach have been used to detect IgG and IgA, in 
addition to IgM and have employed an immunodominant antigen and a 
polyester fabric-resin support in place of nitrocellulose.  
                         A commercial slide agglutination assay has been recently 
found to be as sensitive and specific as an IgM-ELISA, while remaining 
reactive for a shorter time after recovery than either the IgM-ELISA, or the 
MAT.  A number of methods using sensitized red blood cells have been 
described. The extraction of an erythrocyte-sensitizing substance led to the 
development of both a hemolytic assay requiring complement and a 
hemagglutination assay, and a number of modifications of the latter have been 
reported. These assays detect both IgM and IgG antibodies. The number of 
antibody positive subjects in a population depends on two factors: disease 
prevalence and clinical criteria used to select the tested population.  
The indirect hemagglutination assay (IHA) developed at CDC was shown to 
have a sensitivity of 92% and specificity of 95% compared with the MAT. 
A microcapsule agglutination test using a synthetic polymer in place of red 
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blood cells has been evaluated extensively. The microcapsule agglutination 
test is reportedly more sensitive than either the MAT or an IgM-ELISA in 
early acute phase samples, but failed to detect infections caused by some 
serovars. Advantages of this direct agglutination method is that it can be 
applied without modification to sera from other animal species.  
Other techniques applied to the detection of leptospiral antibodies include 
immunofluorescence, RIA, counterimmunoelectrophoresis, and thin-layer 
immunoassay. These methods are not widely used.  
Molecular Diagnosis: 
                      Leptospiral DNA has been detected in clinical material by dot-
blotting and in-situ hybridization.  Several primer pairs for PCR detection of 
leptospires have been described.  A limitation of PCR-based diagnosis of 
leptospirosis is the inability of most PCR assays to identify the infecting 
serovar.  
Molecular typing  
                       There has been great interest in molecular methods for 
identification and subtyping because of the difficulties associated with 
serological identification of leptospiral isolates,. Methods employed have 
included digestion of chromosomal DNA by restriction endonucleases (REA), 
restriction fragment length polymorphism (RFLP), ribotyping, pulsed field gel 
electrophoresis, and a number of PCR-based approaches. 
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TREATMENT 
               Antibiotic treatment is most beneficial if started within 4 days of 
illness; unfortunately, the diagnosis of leptospirosis is rarely made this 
rapidly.  
              Doxycycline, 100 mg orally twice a day for 7 days, started within 48 
hours of illness, decreased the duration of illness by 2 days in one study; 
Penicillin at a dose of 2.4 to 3.6 million units per day also has been successful 
early treatment. A beneficial effect of antibiotic therapy later in disease course 
has not been uniformly seen. While a randomized, double-blinded trial of 
penicillin treatment (1.5 million units intravenously every 6 hours for 7 days) 
started on average nine days into illness showed a decrease in fever duration 
from 11.6 to 4.7 days and in elevated serum creatinine level from 8.3 to 2.7 
days, a second randomized trial of penicillin in patients with icteric 
leptospirosis and a median duration of illness of 1 week demonstrated no 
beneficial effect. Jarish-Herxheimer reactions (fever, rigors, hypotension, and 
tachycardia) rarely occur upon initiation of antibiotic therapy. Supportive care 
and treatment of the hypotension, renal failure (including dialysis), and 
hemorrhage, which can complicate leptospirosis, are crucial for a good 
outcome. 
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Antimicrobial Agents Recommended for 
Treatment and Chemoprophylaxis  of  Leptospirosis 2,3,7 
Indication Compound Dosage 
Chemoprophylaxis Doxycycline 200mg PO orally once per week 
Doxycycline 100 mg bid PO 
Ampicillin 500 – 750 mg q6h PO Treatment of mild 
Leptospirosis# 
Amoxixillin 500 mg q6h PO 
Penicillin G 1.5 MU IV q6h 
Ceftriaxone 1 g IV q24h Treatment of moderate to 
severe Leptospirosis# 
Ampicillin 0.5 – 1 g IV q6h 
#
 All regimens used for the treatment are administered for 7 days 
 
 Immunization of animals is not necessarily effective at preventing 
human disease, since leptospiruria can still occur in immunized animals1. 
Because asymptomatically infected wild animals can chronically excrete large 
numbers of spirochetes in their urine, controlling environmental sources of 
leptospirosis is difficult if not impossible. Occupationally exposed individuals 
(abbatoir workers, veterinarians) should wear protective clothing to prevent 
exposure of skin and mucous membranes to potentially infected urine. Bodies 
of water associated with recreational exposures to leptospirosis may need to 
be placed off limits1. 
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MATERIALS AND METHODS 
Selection criteria: 
• Patients with acute onset of fever and jaundice of less than 10 days 
duration were included in the study.  
• All patients were  ≥ 12 years of age  
• All Pediatric cases were excluded from this study. 
• Patients with chronic liver disease were excluded from this study.  
No of patients selected:  164 
Period of study:   Between 1st August 2004  to  31st December 2005 
              All patients were adult of  ≥ 12 years of age who were admitted as    
in-patients in the Medicine Department in Thanjavur Medical College 
Hospital for acute onset of fever and jaundice. 
Study design:  Prospective study.       
METHODS 
               All patients admitted in Thanjavur Medical College Hospital with 
fever and jaundice were evaluated. History was taken regarding duration of 
fever and duration of jaundice, occupation and history of travel.  
               Symptoms other than fever and jaundice  viz. headache, nausea, 
vomiting, abdominal pain, diarrhea, cough, hemoptysis, anorexia, myalgia, 
conjunctival suffusion, oliguria, hematuria, etc., were noted. 
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                      Signs like rashes, signs of dehydration, lymphadenopathy, 
hepatomegaly, splenomegaly, anaemia, abdominal tenderness, muscle 
tenderness, signs of meningeal irritation, altered sensorium, etc., were also 
noted. 
                      Investigations like routine urinary examination, urine for bile 
salts and bile pigments, complete hemogram, ESR, Liver function tests, Renal 
parameters like blood urea, serum creatinine, serum electrolytes and Creatine 
Phosphokinase levels were done on admission. 
                     Blood was taken for Serology for Leptospirosis for all patients 
with history of more than one week of fever was taken. The blood samples 
were sent to the Institute of Vector Control and Zoonoses (IVCZ), Hosur, 
where samples were analyzed for leptospiral antibodies using Microscopic 
Agglutination Test (MAT). Only one sample was taken from each patient due 
to non availability of testing centre in Thanjavur and due to delay in obtaining 
the initial serology report. 
                     During the hospital stay, all the patients were subjected again to 
liver function tests every week. The renal function tests were repeated every 
third day unless the patient developed ARF for whom the tests were done 
daily. 
                     Follow up of all patients regarding treatment and outcome were 
done during the hospital stay. 
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RESULTS 
Incidence:  
• No. of cases admitted with fever and jaundice: 164 
• No. of cases found serologically positive for leptospirosis: 40 
 Incidence of leptospirosis among patients admitted with fever and                                                        
jaundice is  24% 
(A positive case is one with a MAT titre of more than 1:200 among patients 
presenting with fever and jaundice- as per CDC case definition 1997 1,4 and 
National Institute of Communicable Diseases- NICD case definition 2001. 5) 
# One Patient was positive both for Leptospiral serology and peripheral smear 
for Plasmodium falciparum. 
ANALYSIS OF POSITIVE CASES: 
Age Distribution: 
Age No. of patients Percentage 
12 – 20 years 6 15% 
21 – 30 years 11 27.5% 
31 – 40 years 12 30% 
41 – 50 years 6 15% 
51 – 60 years 4 10% 
> 60 years 1 2.5% 
Sex Distribution: 
No. of  male cases      : 33 (82.5%) 
No. of female cases    : 7   (17.5%) 
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DEMOGRAPHIC DISTRIBUTION 
                                                                     
 
 
 
 
 
 
 
 
 
Except for two cases which were from 
Chennai, all the cases were in and 
around Thanjavur, particularly along 
the Cauvery and Kollidam rivers 
Bay of Bengal 
• Location of Thanjavur Medical College Hospital                     
• District Headquarters                         
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DISTRIBUTION  OF SIGNS AND SYMPTOMS: 
Symptom/Sign No. of Patients Percentage 
Fever 40 100% 
Jaundice 40 100% 
Headache 25 62.5% 
Nausea/Vomiting 12 30% 
Abdominal Pain 9 22.5% 
Diarrhoea 10 25% 
Cough 15 37.5% 
Oliguria 7 17.5% 
Anorexia 31 82.5% 
Myalgia 38 95% 
Hematuria 3 7.5% 
Hematemesis 1 2.5% 
Hemoptysis 5 12.5% 
Conjunctival Suffusion 25 62.5% 
Rash 3 7.5% 
Dehydration 10 25% 
Lymphadenopathy 1 2.5% 
Hepatomegaly 7 17.5% 
Splenomegaly 1 2.5% 
Anaemia 9 22.5% 
Abdominal Tenderness 5 12.5% 
Muscle Tenderness 7 17.5% 
Meningeal Signs 0 0% 
Altered Sensorium 12 30% 
• Average duration of fever on presentation is 6.4 days 
• Average duration of jaundice on presentation is 1.6 days 
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Distribution of Clinical Profile
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A male patient with jaundice on initial presentation  
 
 
A female patient with jaundice on initial presentation  
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A patient with jaundice and Subconjunctival Hemorrhage 
 
 
 
A Leptospirosis patient with Bilateral Pneumonia. 
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OCCUPATION: 
Occupation No. of Cases Percentage 
Manual Workers 25 62.5% 
Non Manual Workers 6 15% 
House Wives 2 5% 
Students 6 15% 
Retired 1 2.5% 
 
ANALYSIS OF LAB INVESTIGATIONS: 
• All the seropositive patients were positive for Bile salts and Bile 
pigments in urine. 
Complete Hemogram: 
Hemoglobin 
• The Mean Hemoglobin values  was  9.88 gms%. 
• Range – 5.8 to 13.1gms%. 
• Six patients had hemoglobin  ≤8gms%. 
WBC Count: 
• The Mean Total Count of WBCs was 8262 cells/µL. 
• Range – 3200 to 14,200 cells/µL. 
Platelet Count: 
• The Mean Platelet Count was 1.63 lakhs/µL. 
• Range – 86,000 to 2.32 lakhs/µL. 
• Three Patients had Platelet Count  <1 lakh/µL. 
Erythrocyte Sedimentation Rate: 
• Mean ESR at 1 hour was  56 mm. 
• Range 16 to 140mm. 
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LIVER FUNCTION TESTS:     Bilirubin: 
 
On Admission Mean Range 
Total Bilirubin 8.36 mg/dL 3.2 – 28.9 mg/dL 
Indirect Bilirubin 3.65 mg/dL 1.4 – 11.7 mg/dL 
Direct Bilirubin 4.71 mg/dL 1.1 – 16.1 mg/dL 
Other Liver Function Tests: 
Tests Mean Range 
SGOT                             (U/L) 58.7 22 – 240 
SGPT                             (U/L) 57.7 18 – 232 
Alkaline Phosphatase    (IU/L) 116.9 53 – 246 
Total Protein                (gms/dL) 6.4 5.1 – 7.2 
 
On Admission After 1 week of treatment  
Total 
Bilirubin 
(mg/dL) No. of Patients Percentage No. of Patients Percentage 
≤ 2 None 0% 20 50% 
2.1 – 4 3 7.5% 10 25% 
4.1 – 6 10 25% 2 5% 
6.1 – 8 9 22.5% 1 2.5% 
8.1 – 10 4 10% - - 
10.1 – 12 9 22.5% - - 
12.1 – 14 2 5% - - 
>14 3 7.5% - - 
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 Only 33 Patients were alive 1 week after admission. 
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RENAL FUNCTION TESTS: 
Test Mean Range 
Blood Urea            (mg/dL) 51.7 26 to 127 
Sr. Creatinine        (mg/dL) 1.8 0.8 to 7.4 
Serum Creatinine levels: 
Sr. Creatinine     (mg/dL) No. of Patients Percentage 
< 1.5 22 55% 
1.5 – 2.0 8 20% 
2.1 – 2.5 3 7.5% 
>2.5 7 17.5% 
Blood Urea  levels: 
Blood Urea  (mg/dL) No. of Patients Percentage 
≤ 40 22 55% 
41 – 60 7 17.5% 
61 – 80 4 10% 
81 – 100 4 10% 
>100 3 7.5% 
 
 After rehydration, renal parameters returned to normal range except for 
six patients who needed nephrologist’s intervention and dialysis. 
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Serum Creatine Phospho Kinase (CPK): 
 Mean CPK  value is   361 U/L. (Normal < 200 U/L) 
 Range : 90 to 656 U/L 
TREATMENT: 
 All patients were started on Inj. Benzyl Penicillin 20 Lakhs Units 
Intravenously – four times daily.  
 All patients were started on Penicillin from the day of admission after 
test dose. 
 None of the Patients were allergic to Penicillin. 
 Treatment with Penicillin was given for a minimum of 7 days. 
END POINTS:   
 Whether the Patient is cured and discharged or the Patient succumbed to 
the illness. 
• No. of Patients discharged after cure : 32 
• No. of Patients Expired                      :  8. 
DURATION OF HOSPITAL STAY: 
Among the 32 Patients who were discharged,  
• Mean duration of hospital stay was : 9.15 (Range 7 to 21 days) 
Among the 8 patients who died, 
• Mean duration of hospital stay was : 5.5 days (Range 2 – 18 days) 
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COMPLICATIONS: 
Complication No. of 
Patients 
No. 
cured No.Expired Mortality 
Renal Failure 
(Persistent after correction of 
dehydration) 
7 5 2 40% 
Lung Consolidation  2 2 - 0% 
Bleeding Disorders 
(Hematemesis, Hematuria, 
Thrombocytopenia, DIC) 
3 1 2 66% 
Encephalopathy  
(Metabolic, Hepatic) 
9 5 4 44% 
 Other complications like Ocular complications, Cardiac complications, etc. were not 
seen.  
RENAL FAILURE: 
 Oliguria and elevated renal parameters even after rehydration was present in 
7 patients 
 No. of cases for which Peritoneal Dialysis was Performed : 7 patients 
 Normal Renal Function Restored in 5 patients. 
 On an average, 2-3 cycles of PD were done per patient. 
 No. expired despite treatment: 2 Patients   
MORTALITY: 
No. of Cases Expired – 8 
Mortality rate is 8/40 – 20%  
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Analysis of Complications
0
0 2 4 6 8 10
Renal Failure
Lung Consolidation
Bleeding Diathesis
 Encephalopathy
Total no. of cases No. of cases recovered No. of cases expired
 
 
OUTCOME 
 
No of cases 
cured and 
discharged  
     32 
 (80%) 
No of cases 
Expired   
       8 
   (20%) 
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DISCUSSION 
  Among the patients admitted with fever and jaundice, the 
incidence of Leptospirosis was 24%.  
          Most of the patients were in the working group aged between 20 
and 40 years. Further most of them were males (M:F=5:1). This explains that 
males frequently go out of their homes for work and males also have greater 
predilection for acquiring the disease (Hormonal factors).54  
  Further the analysis of the occupation reveals that most of them 
were laborers (62.5%) working in the fields or businessmen with frequent 
history of travel. Muthusethupathi et al17 gives the incidence among manual 
labourers as 49%.  
                  The assessment of Demographic and Seasonal distribution plays 
an important role in this study. Thanjavur and its surrounding areas is well 
known for its rice cultivation (hence called ‘Rice Bowl’ of Tamilnadu), 
especially the ‘Kuruvai’ crops which are cultivated during the months of 
October to January. It is the period during which Northwest monsoon is active 
in Tamilnadu. 
  Though cases occurred in areas scattered in and around Thanjavur, only 
two cases were from seashore regions like Nagapattinam and Peravurani and 
four from dry areas like Perambalur, Ariyalur and Pudukottai. Otherwise most 
of the cases (32 cases) were from areas along Cauvery river and its Delta  
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distributaries and its main distributary Kollidam – especially from places like 
Thiruchirapalli, Lalgudi, Thirukattupalli, Thanjavur, Thiruvaiyaru, Thirumanur,  
Elakurichi, Papanasam, Kumbakonam, Thiruvarur, etc. 
  Further as far as the Seasonal Distribution of cases were 
concerned, most of the cases were admitted during the months of October, 
November and December during which the Northwest monsoon is active in 
Tamil Nadu though sporadic cases were also seen during other months of the 
year. 
 It is evident from these observations that during the rainy season which 
usually brings water into the river Cauvery and its branches, incidence of 
Leptospirosis is greater which attributes that the source of infection is 
probably the contaminated river water. 
 Further it is during this period that ploughing of rice fields, sowing and 
transplantation of saplings are active in this region which needs 
prolonged contact with water. 
 Hence the disease may not be endemic in this region. The Leptospira 
infecting the people could be brought by the river water from the 
upstream areas along the Cauvery River to the delta region. Further 
analysis is needed to find out the serovars infecting the community. 
 Padre et al55 describes increased incidence of Leptospirosis among rice 
field workers.  
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ANALYSIS OF CLINICAL FEATURES: 
                 Since this study was performed in patients presenting with fever and 
jaundice, other clinical symptoms and signs were analyzed on admission. 
• The mean duration of history of Fever was 6.4 days on admission with the 
range between 4 to 9 days. 
• The mean duration of history of Jaundice was 1.6 days on admission. 
                 Until jaundice was noted by the clinician or by themselves, most of 
the cases were treated as outpatients for fever. Some of them took self treatment 
with antipyretics. 
 Among the symptoms other than fever and jaundice, most cases 
presented with Myalgia (38 cases, 95%), anorexia ( 31 cases, 82.5%) and 
headache (25 cases, 62.5%). Rarer symptoms noted in our study were hematuria 
(7.5%), hematemesis (2.5%), and hemoptysis (12.5%). 
          Common signs seen during admission were conjunctival suffusion (25 
cases, 62.5%), altered sensorium (12 cases, 30%) and dehydration (10 cases, 
25%). Rare signs noted were lymphadenopathy (2.5%), splenomegaly (2.5%) 
and rash (7.5%). The rashes noted were erythematous macules which 
disappeared within few days of starting treatment. 
 After treatment, except for cases which expired, all the patients improved 
clinically. Dehydration was corrected immediately on admission except for 
cases with oliguria and renal failure. The sensorium also improved in most of 
the patients on starting treatment. 
  
60
60
COMPARISON OF SIGNS AND SYMPTOMS ON ADMISSION  
in patients with Leptospirosis   
        IN LARGE CASE SERIES AND IN THIS STUDY 10, 17, 11, 12,      
(% of patients) 
Signs and Symptoms China
10
  
1965 
n = 168 
India17 
1992 
n = 57 
Brazil11 
1999 
n = 193 
India12 
2002 
n = 74 
In this 
Study* 
n = 40 
Jaundice 0 84 95 34 100 
Anorexia 46 85 - - 82.5 
Headache 90 26 75 92 62.5 
Conjunctival 
Suffusion 
57 58 28.5 35 62.5 
Vomiting 18 58 - - 30 
Myalgia 64 82 94 68 95 
Abdominal Pain 26 18 - - 22.5 
Dehydration - 39 - - 25 
Cough 57 32 - - 37.5 
Hemoptysis 51 9 20 35 12.5 
Hematemesis/Melena - 26 - - 2.5 
Hepatomegaly 28 - - - 17.5 
Lymphadenopathy 49 - - 15 2.5 
Diarrhoea 20 26 - - 25 
Arthralgia 36 - - 12 - 
Rash - - - 12 7.5 
Meningeal signs - 7 - - - 
Altered Sensorium - 42 - - 30 
*Though other studies included patients with fever alone, our study included patients                             
presenting with both fever and jaundice. 
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ANALYSIS OF LABORATORY INVESTIGATIONS: 
  All the patients in our study who had fever and jaundice on 
admission were positive for Bile Salts and Bile Pigments in Urine which 
revealed the presence of Hyperbilirubinemia by bed side. 
Complete Hemogram: 
  Complete Hemogram revealed that most of the patients had normal 
Hemoglobin levels except for six of them for whom the hemoglobin levels were  
≤ 8 gms/dL. Further analysis revealed that among the six patients, all of them 
presented with hemoptysis, three of them presented with hematuria and one 
with hematemesis. 
  The total count of  WBCs revealed mild Leucocytosis in four cases 
(10%) – while in others it was within normal limits. The Differential Count 
revealed mild Neutrophilia in three cases (7.5%). 
  Most of them had normal Platelet Count. Only in three patients 
(7.5%), the Platelet Count was less than 1 lakh/µL. All the three patients 
presented with bleeding manifestations. 
  There was a mild rise in Erythrocyte Sedimentation Rate in most 
of the patients. Five (12.5%) of the patients had ESR above 100mm in 1 hour. 
  It is evident from these observations that non-specific changes in 
Hemogram can occur in Leptospirosis. Though they are not useful in the 
diagnosis of disease, they are helpful in suspicion of the disease. 
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Liver function tests: 
  The Analysis of LFT reveals a high level of Bilirubin on admission 
ranging from 3.2 to 28.9 mg/dL. There was a Conjugated Hyperbilirubinemia in 
most of the cases. Almost all of them who responded to treatment had marked 
reduction in their Bilirubin levels after 1 week. 
  There was mild increase in Serum Transaminase levels while there 
was a moderate increase in Serum Alkaline Phosphatase levels. The Total 
Protein level was within normal limits. Further follow-up of the patients during 
the hospital stay revealed that the enzyme levels returned to normal on 
treatment. 
Renal Function Tests: 
            While only seven patients presented with oliguria, laboratory 
investigations revealed mild to severe elevation of Blood Urea and Serum 
Creatinine levels in 45% of  patients. Among them, 10 patients (25%) had 
serum creatinine levels of more than 2mg/dL and 11 (27.5%) patients had 
Blood Urea level of more than 60mg/dL including three of them with levels 
more than 100mg/dL. 
  Further it was noted that after Rehydration with oral or intravenous 
fluids, most of the patients with mild raise in Renal Parameters returned to 
normal levels except in seven patients (17.5%) for whom Nephrologist’s 
intervention was needed. 
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          There was a mild to moderate elevation of Serum Creatine 
Phospho Kinase levels during admission for 32 (80%) patients, which reveals 
the acute nature of the disease. The maximum value was 656 U/L (normal – less 
than 200 U/L). 
ABNORMAL BIOCHEMICAL VALUES: 
Comparison with a study conducted in Chennai 
Muthusethupathi 
et.al 17 
n = 57 
In our study 
 
n = 40 
Parameter Abnormal  
values 
No. of  
cases 
Percentage No. of 
cases  
Percentage 
Blood Urea       >40 mg/dL 41 72 18 45 
Sr.Creatinine       >1.5 mg/dL 41 72 18 45 
Bilirubin >2.0 mg/dL 48 82 40 100 
SGOT >40 U/L 25 44 21 52.5 
SGPT >40 U/L 27 47 22 55 
Platelets < 1 lakh/µL 13 23 3 7.5 
 
Co-infection with Pl. falciparum Malaria was seen in one case in this 
study. This coincides with various studies on Leptospirosis with concomitant 
illnesses, viz. Malaria46, Hepatitis, Dengue34, Melioidosis, Scrub typhus, etc. 
Wongsrichanalai et al 46 reported two cases of dual infection with malarial 
parasites and leptospira. One patient was infected with Plasmodium falciparum 
and the other with P. vivax. 
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 The outcome of the treatment revealed that all the patients were 
sensitive to Benzyl Penicillin injection given intravenously. Most of the patients 
also received a presumptive treatment with Chloroquine for Malaria. Only one 
patient was proved to have multiple infections with Leptospira and Plasmodium 
falciparum malaria. 
 The common complications were mostly renal failure (7 cases) 
with some presenting with altered sensorium (12 cases). Moreover outcome was 
good in patients with renal failure with death occurring in 2 out of seven cases 
(28%) whereas among the three patients who presented with bleeding disorders, 
the mortality was 66%. Among the 2 cases which presented with features of 
consolidation, with chest X-Ray showing Homogenous Opacities, the outcome 
was excellent with both cases getting cured and discharged. Renal failure 
patients received Peritoneal Dialysis with good results (5 out of 7 cured). 
Muthusethupathi et al14 too reveals that peritoneal dialysis is satisfactory. Other 
complications including Cardiac complications like arrhythmias, myocarditis, 
Ocular complications like Uveitis, Cerebrovascular Accident, Acalculous 
Cholecystitis, Arthritis, GBS, etc. – which are described in textbooks 1,2,3,7 were 
not noted in this study. 
  This study also reveals a high mortality rate for complicated Icteric 
leptospirosis of 20% (8cases). Levett PN 1 gives the mortality rate as  5-15%. 
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CONCLUSION 
 
 
1) The incidence of Leptospirosis among adults admitted with 
fever and jaundice was 24%. 
2) Most of the cases (80%) were from the places along the 
Cauvery and Kollidam rivers and their Delta distributaries. 
3) Most of the cases occurred during the monsoon months of 
October, November and December.  
4) The infection may not be endemic to this region but could be 
brought from upstream areas of Cauvery River during rainy 
season. 
5) Most of the cases were manual workers (62.5%). 
6) Apart from fever and jaundice, the most common 
symptoms/signs present during admission in patients with 
Leptospirosis were Myalgia, Anorexia, Headache and 
Conjunctival Suffusion. 
7) Mixed infection of Leptospirosis with Plasmodium falciparum 
was seen in one case. 
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8) All the cases had hyperbilirubinemia mostly of conjugated 
type. 
9) Most of them had prerenal azotemia which was corrected by             
rehydration. 
10) Mild to moderate elevation of CPK levels was seen in 80% 
cases. 
11) All alive patients responded well to intravenous Penicillin 
therapy. 
12) Seven cases (17.5%) went for Intrinsic Acute Renal Failure 
with five of them recovering with Peritoneal Dialysis. 
13) The overall mortality of the Icteric Leptospirosis cases was 
20%. 
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PROFORMA 
 
 
   NAME:                                            Age:                 IP No: 
 
   Date of Admission:                        Sex: M□     F□     
 
   Ward/ Unit:  
                                                                                                                 
   Address:                                                    
 
Occupation:      □ Manual Worker 
                              □ Non Manual Worker 
                              □ House wife                                                       
                           □ Student 
                           □ Retired 
 
SYMPTOMS  and SIGNS: 
 
□ Jaundice: ____days          □ Fever: ____days             □ Headache                                                                                     
□ Nausea / Vomiting           □ Abdominal Pain              □ Diarrhoea                                          
□ Cough                               □  Hemoptysis                    □ Anorexia                                                              
□ Conjunctival Suffusion    □ Myalgia                           □ Chills 
□ Oliguria /Anuria              □ Haematuria      
                            
□ Rash                                 □ Dehydration                □ Lymphadenopathy                                                
□ Hepatomegaly                  □ Anaemia                     □ Splenomegaly                
□Abdominal Tenderness     □ Muscle tenderness                                    
□ Meningeal signs               □ Altered sensorium                                       
□ Others: 
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INVESTIGATIONS: 
Serology  for Leptospirosis: 
 
Urine:         Albumin:                                                  
                     Sugar    :                                                  
                     Deposits:  
                     Bile Salts: 
                     Bile Pigments:                                                                         
Hemogram:                                                                                           
Hb         :                          g %                                                            
TC         :                           cells/µL                                                               
DC         :   P:       , L:       , E:      %                                                                   
Platelets :                         cells/µL                                                                      
RBC      :                          cells/µL                                                        
ESR       : ½ hr:           mm                                              
                 : 1  hr:            mm      
                                                              
Blood Biochemistry:                                           
Sr. CPK :  U/L 
Parameters Day 1 Rpt Rpt 
Blood Sugar             mg/dL    
Blood Urea               mg/dL    
Sodium                     mEq/L    
Potassium                 mEq/L    
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Liver Function Tests:   
Date: Day 1 After 1 week 
Total Bilirubin                          mg/dl     
Direct Bilirubin                         mg/dl    
Indirect Bilirubin                      mg/dl   
SGOT                                 U/L   
SGPT                                           U/L   
Sr.Alkaline Phosphatase:           IU/L    
Total Protein                        g/dL   
   
Ultrasound Abdomen:   
 
 
Chest X Ray: 
 
 
ECG : 
 
 
Other Investigations: 
 
 
 
TREATMENT GIVEN: 
 
 
 
 
CLINICAL OUTCOME: 
 
    □  Cured and Discharged 
    □  Expired  
 
    Duration of stay in hospital: ____days. 
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1 ARIVAZHAGAN 38 M Lalgudi 801557 MW 6.8.04 5 2 √ √ √ √ √ √ Positive
2 PRAKASH 13 M Papanasam 803002 S 12.8.04 4 1 √ √ Positive
3 SAKTHIVEL 31 M Trichy 804241 MW 26.8.04 9 2 √ √ √ √ √ √ √ √ √ √ √ √ √ Positive
4 BASKAR 25 M Papanasam 811053 MW 17.9.04 5 1 √ √ √ Positive
5 JAWAHAR 22 M Nagapattinam 812330 MW 28.9.04 7 3 √ √ √ √ √ √ Positive
6 NAGARAJ 47 M Papanasam 816858 NMW 3.10.04 8 3 √ √ √ √ √ √ √ √ √ √ Positive
7 CHITRA 24 F Peravurani 817253 HW 11.10.04 5 2 √ √ √ √ √ √ √ √ Positive
8 NATESAN 47 M Orathanadu 817233 MW 6.10.04 6 1 √ √ √ Positive
9 SASIKUMAR 25 M Thiruvaiyaru 817693 MW 10.10.04 6 1 √ √ √ Positive
10 ASAITHAMBI 44 M Nannilam,Thiruvarur 817320 NMW 8.10.04 5 2 √ √ √ Positive
11 CHINNADURAI 35 M Kumbakonam 817830 MW 11.10.04 7 1 √ √ √ √ √ √ √ √ √ √ √ √ Positive
12 CHELLADURAI 45 M Vallam 819103 MW 21.10.04 5 1 √ Positive
13 DHAYANIDHI 21 M Orathanadu 820012 MW 29.10.04 8 3 √ √ √ Positive
14 RAJESH 31 M Pulivalam,Thiruvarur 820431 MW 4.11.04 7 2 √ √ √ √ Positive
15 SIVARAJ 15 M Papanasam 820729 S 9.11.04 6 1 √ √ √ √ Positive
16 NEELA 25 F Pudukottai 821346 MW 15.11.04 7 2 √ √ √ √ Positive
17 RAJENDRAN 37 M Thirumanur 821941 MW 19.11.04 8 2 √ √ √ √ √ √ √ √ √ √ √ √ Positive
18 SHANMUGAVEL 28 M Thiruvarur 822293 MW 22.11.04 9 3 √ √ √ √ √ √ √ √ √ Positive
19 SIVAKUMAR 40 M Trichy 823645 NMW 5.12.04 7 1 √ √ √ √ √ √ √ √ √ √ √ √ Positive
20 MURUGAIYAN 50 M Thanjavur 829373 NMW 22.1.05 7 1 √ √ √ Positive
21 HARINI 28 F Thanjavur 832491 HW 16.2.05 6 1 √ √ Positive
22 HARIHARAN 31 M Thanjavur 838674 MW 11.3.05 5 2 √ √ √ √ Positive
23 MALATHI 17 F Kumbakonam 840363 S 19.5.05 8 3 √ √ √ √ √ √ √ √ √ √ √ √ √ √ Positive
24 SANTHANAKRISHNAN 60 M Trichy 840832 NMW 11.6.05 6 1 √ √ √ Positive
25 RAJENDRAN 40 M Thirukattupalli 849906 MW 7.7.05 4 1 √ √ √ √ √ √ √ √ √ √ Positive
26 KUMAR 35 M Thanjavur 853482 MW 6.8.05 5 1 √ √ √ Positive
27 VIVEKANANDAN  # 38 M Chennai 855517 NMW 21.9.05 9 3 √ √ √ √ Positive
28 KALIYAPERUMAL 55 M Mannargudi 861659 MW 5.10.05 6 1 √ √ √ √ Positive
29 JOHN 47 M Perambalur 863138 MW 19.10.05 7 1 √ √ Positive
30 AROKYARAJ 23 M Elakurichi 863520 MW 23.10.05 8 2 √ √ √ √ √ √ √ √ √ √ √ √ Positive
31 CHANDRAKALA 25 F Kantharvakottai 863135 MW 19.10.05 6 1 √ √ Positive
32 VELU 70 M Thiruvaiyaru 864738 R 5.11.05 7 2 √ √ √ √ √ Positive
33 MATHANKUMAR 19 M Thiruvaiyaru 865341 S 18.11.05 6 1 √ √ Positive
34 RAJENDRAN 40 M Thanjavur 867920 MW 28.11.05 5 1 √ √ √ √ Positive
35 MANI 60 M Ariyalur 869365 MW 18.12.05 6 1 √ √ √ Positive
36 JAMUNA 12 F Thanjavur 870012 S 19.12.05 5 1 √ √ √ Positive
37 RAVICHANDRAN 35 M Pudukottai 863280 MW 12.12.05 5 1 √ √ √ √ √ √ √ Positive
38 REXCY 18 F Chennai 869545 S 23.12.05 7 2 √ √ √ √ Positive
39 ALEXANDER 30 M Thanjavur 870116 MW 24.12.05 8 2 √ √ √ √ √ √ √ √ √ √ Positive
40 KALYANASUNDARAM 52 M Needamangalam 851679 MW 21.7.05 6 2 √ √ √ √ √ √ √ √ √ Positive
*MW:Manual Worker, NMW:Non Manual Worker, HW:House Wife, S:Student, R:Retired             # also positive for Plasmodium falciparum  in peripheral smear
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1 ARIVAZHAGAN 11.2 5400 1.2 122 8.6 4
2 PRAKASH 10.4 7100 0.96 16 14.2 8.4
3 SAKTHIVEL 7.8 13000 1.82 28 4.2 2
4 BASKAR 13.1 7800 2.1 44 6.8 4.2
5 JAWAHAR 11.2 6400 1.6 62 11.2 6.2
6 NAGARAJ 10.4 9600 2.2 52 11.4 6.1
7 CHITRA 8 12600 2.12 24 10.2 5.4
8 NATESAN 9.6 9600 1.4 28 4.8 3
9 SASIKUMAR 9.4 3200 1.6 122 9.2 4.1
10 ASAITHAMBI 11.2 7200 2.32 32 4.2 2.1
11 CHINNADURAI 7.8 13300 0.86 64 6.8 5
12 CHELLADURAI 12.6 6400 1.62 56 11.2 7.1
13 DHAYANIDHI 12.8 9100 1.7 32 10.4 5.8
14 RAJESH 10.2 8200 1.42 32 6.8 3.8
15 SIVARAJ 9.8 6100 2.4 84 5.4 3.4
16 NEELA 9 5400 1.45 72 3.8 1.8
17 RAJENDRAN 8.1 11600 1.62 90 8.4 5.1
18 SHANMUGAVEL 7.2 9600 1.71 22 10.2 5.1
19 SIVAKUMAR 7.8 10400 2 70 3.2 1.1
20 MURUGAIYAN 9 6100 1.32 126 4.2 2.8
21 HARINI 9.8 5600 1.64 32 6.4 3
22 HARIHARAN 11.2 11700 1.72 18 4.2 2.1
23 MALATHI 6.2 14200 1.1 24 3.8 2.1
24 SANTHANAKRISHNAN 12.6 3100 1.2 32 6.6 3.6
25 RAJENDRAN 11.2 5600 0.98 64 4.2 2.2
26 KUMAR 12.6 7200 1.6 96 12.1 8
27 VIVEKANANDAN 8.8 5400 1.32 84 10.4 6
28 KALIYAPERUMAL 10.6 6200 1.4 22 28.9 16.1
29 JOHN 11.2 9100 1.62 18 17.2 11.1
30 AROKYARAJ 5.8 11700 1.25 140 5.6 2.1
31 CHANDRAKALA 10.8 7100 1.62 64 9.6 5.2
32 VELU 10 4400 1.74 110 7.2 4.1
33 MATHANKUMAR 8.8 3600 2.1 32 11.2 5.1
34 RAJENDRAN 11.2 9100 2.2 16 13.6 7.1
35 MANI 9.6 12200 1.82 30 6.8 3.2
36 JAMUNA 10.4 8900 1.6 62 5.4 4
37 RAVICHANDRAN 9.9 9600 1.5 62 6.4 3.2
38 REXCY 9.4 11000 2.1 18 5.2 3.1
39 ALEXANDER 8.1 8900 1.8 51 7.4 4.2
40 KALYANASUNDARAM 10.2 7800 1.6 96 11.6 6.4
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4.6 50 45 96 6 38 1.2 420 111
5.8 40 36 112 6.2 28 0.9 610 92
2.2 52 48 102 5.8 98 3.7 540 128
2.6 46 50 96 5.8 42 1.4 316 70
5 240 232 180 6.2 46 1.5 240 76
5.3 40 36 126 6.4 110 4.1 656 92
4.8 72 64 112 7 30 0.8 180 84
1.8 90 92 140 6.4 84 3.2 245 110
5.1 40 41 84 5.8 28 0.9 360 116
2.1 40 38 176 6.8 26 0.9 450 98
1.8 42 36 152 7 34 1.2 410 76
4.1 40 44 86 7 32 1 520 62
4.6 42 40 92 6.8 28 1.1 634 140
3 40 36 106 5.6 42 1.4 130 96
2 42 38 112 5.8 96 3.4 270 132
2 54 50 86 6 41 2.3 310 121
3.3 198 196 240 6.8 60 1.5 570 126
5.1 40 36 118 6.8 70 1.8 530 96
2.1 42 40 96 7 64 1.7 310 92
1.4 38 45 64 6.6 32 0.9 110 98
3.4 50 56 102 6.4 36 1.1 129 104
2.1 62 64 92 6.8 42 1.7 260 96
1.7 40 36 112 7.2 62 1.6 140 136
3 70 72 122 7 32 1 320 126
2 84 90 142 6.8 94 3.1 190 121
4.1 42 40 102 5.6 32 1 380 96
4.4 38 40 114 6.8 28 1.2 430 92
11.7 117 106 296 6.8 127 7.4 90 84
6.1 42 40 76 7.2 34 1 410 72
3.5 56 63 160 5.8 60 2.6 620 70
4.4 40 41 84 5.9 34 1.2 325 96
3.1 38 32 96 6 32 1 420 122
6.1 40 36 108 7 36 1.2 290 126
6.5 120 126 186 6.8 38 1.6 200 96
3.6 40 36 110 6.4 40 1.8 170 74
1.4 38 41 86 5.9 78 2.4 350 94
3.2 45 41 90 6.2 32 1.1 400 96
2.1 38 36 92 6.1 40 1.2 320 106
3.1 40 51 78 5.6 38 1.1 610 94
5.2 22 18 53 5.1 126 6.2 590 95
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1.2 13 Cured
4.1 8 Cured
4 Expired
0.9 8 Cured
2 Expired
3 Expired
2.9 20 Cured
1.1 10 Cured
1.3 8 Cured
1.1 11 Cured
4.9 18 Expired
2.4 8 Cured
2.6 9 Cured
1.2 17 Cured
1.1 7 Cured
1.7 4 Cured
1.9 9 Cured
2.8 10 Cured
6 Expired
1.4 20 Cured
1.5 12 Cured
1.7 11 Cured
4 Expired
0.9 9 Cured
1.2 10 Cured
3.3 8 Cured
2.4 17 Cured
6.8 21 Cured
3.1 12 Cured
3 Expired
0.9 9 Cured
0.8 11 Cured
3.1 9 Cured
2.3 10 Cured
1.7 8 Cured
1.3 9 Cured
4 Expired
1.1 13 Cured
1.4 16 Cured
3.1 19 Cured
